4.4(top 5%)
impact factor
557(top 50%)
papers
11.8K(top 20%)
citations
54(top 10%)
h-index
4.5(top 5%)
impact factor
700
all documents
12.2K
doc citations
89(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Cardiovascular Protective Effects of ResveratrolCardiovascular Drug Reviews2004450
2Role of Poly(ADP‐ribose) polymerase 1 (PARP‐1) in Cardiovascular Diseases: The Therapeutic Potential of PARP InhibitorsCardiovascular Drug Reviews2007282
3The Many Faces of H89: A ReviewCardiovascular Drug Reviews2006275
4Olprinone: A Phosphodiesterase III Inhibitor with Positive Inotropic and Vasodilator EffectsCardiovascular Drug Reviews2002242
5C-Reactive Protein (CRP)-Lowering AgentsCardiovascular Drug Reviews2006228
6Prasugrel: A Novel Thienopyridine Antiplatelet Agent. A Review of Preclinical and Clinical Studies and the Mechanistic Basis for Its Distinct Antiplatelet ProfileCardiovascular Drug Reviews2007227
7Cardiovascular Actions of BerberineCardiovascular Drug Reviews2001226
8Clopidogrel, A Novel Antiplatelet and Antithrombotic AgentCardiovascular Drug Reviews1993206
9A Review on Telmisartan: A Novel, Long‐Acting Angiotensin II‐Receptor AntagonistCardiovascular Drug Reviews2000176
10Therapeutic Use of Citrulline in Cardiovascular DiseaseCardiovascular Drug Reviews2006176
11Cilostazol (Pletal®): A Dual Inhibitor of Cyclic Nucleotide Phosphodiesterase Type 3 and Adenosine UptakeCardiovascular Drug Reviews2001172
12Rosuvastatin: A Highly Effective New HMG‐CoA Reductase InhibitorCardiovascular Drug Reviews2002160
13PerhexilineCardiovascular Drug Reviews2007152
14Fondaparinux, a Synthetic Pentasaccharide: The First in a New Class of Antithrombotic Agents — The Selective Factor Xa InhibitorsCardiovascular Drug Reviews2002144
15Pharmacological Actions of Sodium Ferulate in Cardiovascular SystemCardiovascular Drug Reviews2005142
16Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin-II AntagonistCardiovascular Drug Reviews1995121
17Antiatherogenic Properties of Naringenin, a Citrus FlavonoidCardiovascular Drug Reviews1999119
18Therapeutic Effects of Guggul and Its Constituent Guggulsterone: Cardiovascular BenefitsCardiovascular Drug Reviews2007113
19Pitavastatin: Efficacy and Safety Profiles of A Novel Synthetic HMG‐CoA Reductase InhibitorCardiovascular Drug Reviews2003108
20Carvedilol: Molecular and Cellular Basis for Its Multifaceted Therapeutic PotentialCardiovascular Drug Reviews2001106
21Basic Experimental Studies and Clinical Aspects of Gadolinium Salts and ChelatesCardiovascular Drug Reviews2001103
22Trimetazidine, A Cellular Anti-ischemic AgentCardiovascular Drug Reviews1988102
23Angiotensin‐(1‐7): Pharmacology and New Perspectives in Cardiovascular TreatmentsCardiovascular Drug Reviews2007100
24Tolvaptan, an Orally Active Vasopressin V2‐Receptor Antagonist—Pharmacology and Clinical TrialsCardiovascular Drug Reviews200797
25Ro 40?5967: A New Nondihydropyridine Calcium AntagonistCardiovascular Drug Reviews199196
26SR 90107A/Org 31540, a Novel Anti-Factor Xa Antithrombotic AgentCardiovascular Drug Reviews199796
27Eplerenone: A Selective Aldosterone Receptor Antagonist (SARA)Cardiovascular Drug Reviews200195
28Oxidative Stress as the Leading Cause of Acute Myocardial Infarction in DiabeticsCardiovascular Drug Reviews200692
29Clinical Use and Molecular Mechanisms of Action of Extract of Ginkgo biloba Leaves in Cardiovascular DiseasesCardiovascular Drug Reviews200491
30Pharmacological Mechanisms Contributing to the Clinical Efficacy of LevosimendanCardiovascular Drug Reviews200591
31Role of Adenosine as Adjunctive Therapy in Acute Myocardial InfarctionCardiovascular Drug Reviews200691
32L-Dihydroxyphenylserine (L-DOPS): A Norepinephrine ProdrugCardiovascular Drug Reviews200687
33Cardiovascular Therapeutic Aspects of Soluble Epoxide Hydrolase InhibitorsCardiovascular Drug Reviews200686
34Pharmacodynamic, Pharmacokinetic and Clinical Effects of Clevidipine, an Ultrashort‐Acting Calcium Antagonist for Rapid Blood Pressure ControlCardiovascular Drug Reviews200485
35Argatroban, A Selective, Potent Thrombin InhibitorCardiovascular Drug Reviews199184
36Pharmacological Effects of Xanthones as Cardiovascular Protective AgentsCardiovascular Drug Reviews200479
37Oxidative Stress and Cardiovascular Disease: Antioxidants and Unresolved IssuesCardiovascular Drug Reviews200675
38The Novel Antiarrhythmic Drug Dronedarone: Comparison with AmiodaroneCardiovascular Drug Reviews200575
39Therapeutic Potentials of Sarpogrelate in Cardiovascular Disease*Cardiovascular Drug Reviews200473
40Pharmacology of Azimilide Dihydrochloride (NE-10064), A Class III Antiarrhythmic AgentCardiovascular Drug Reviews199770
41Ramatroban (BAY u 3405): A Novel Dual Antagonist of TXA2 Receptor and CRTh2, a Newly Identified Prostaglandin D2 ReceptorCardiovascular Drug Reviews200470
42Therapeutic Potential of VIVIT, a Selective Peptide Inhibitor of Nuclear Factor of Activated T cells, in Cardiovascular DisordersCardiovascular Drug Reviews200769
43CilostazolCardiovascular Drug Reviews199367
44Lectin-like Oxidized Low-density Lipoprotein Receptor-1, a New Promising Target for the Therapy of Atherosclerosis?Cardiovascular Drug Reviews200767
45Sulodexide: A Renewed Interest in This GlycosaminoglycanCardiovascular Drug Reviews200665
46Pharmacological Effects of AVE 0991, a Nonpeptide Angiotensin-(1?7) Receptor AgonistCardiovascular Drug Reviews200664
47N‐(p‐Amylcinnamoyl)anthranilic Acid (ACA): A Phospholipase A2 Inhibitor and TRP Channel BlockerCardiovascular Drug Reviews200764
48Phosphomannopentaose Sulfate (PI‐88): Heparan Sulfate Mimetic with Clinical Potential in Multiple Vascular PathologiesCardiovascular Drug Reviews200463
49Ambrisentan, a Non-peptide Endothelin Receptor AntagonistCardiovascular Drug Reviews200661
50Oleamide: A Fatty Acid Amide Signaling Molecule in the Cardiovascular System?Cardiovascular Drug Reviews200760